Parkwalk

Activity from announced rounds

Activity in this selectionOct 24, 2026 · Biotech · Jan 1, 2026
Rounds participated in
2
Confirmed lead rounds
—
2 roles undisclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$33.4M
2 disclosed · full round size, not this investor’s share

By stage

Series C+1
Undisclosed1

By primary sector

Agritech1
Biotech1

By country

United Kingdom2

Rounds

2 in this selection
Moa Technology

An agricultural biotechnology company focused on discovering novel mode of action herbicides

£22.2MSeries C
Role not disclosed
Semarion

Develops next-generation cell assay technology for drug discovery

$3.8MUndisclosed
Role not disclosed